CAS 1159266-37-1

Mogamulizumab

CAS : 1159266-37-1

Mogamulizumab is a monoclonal antibody targeting CC chemokine receptor 4 with anticancer effects, used in ATLL and CTCL studies.

Degré de pureté : SDS-PAGE:97.3%;SEC-HPLC:99.4%

Couleur et forme : Liquid

Masse moléculaire : 146.43 kDa

Ref: TM-T76782

Mogamulizumab

CAS : 1159266-37-1

Anti-Human CCR4 Monoclonal Antibody

Ref: 3D-CLA1268